United States · FDA National Drug Code directory
Lurasidone Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 53746-882_f81d4ba1-6578-46ad-bbc6-7c80a6e37625
- Product NDC
- 53746-882
- Form
- TABLET, COATED
- Composition / generic term
- Lurasidone Hydrochloride
- Labeler
- Amneal Pharmaceuticals of New York LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20240705
- Source listing expiry
- 20261231
Source-listed ingredients
- LURASIDONE HYDROCHLORIDE — 120 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET, COATED in 1 BOTTLE (53746-882-30) · 53746-882-30
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →